Literature DB >> 8176250

Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.

C Garbe1, P Büttner, J Weiss, H P Soyer, U Stocker, S Krüger, M Roser, J Weckbecker, R Panizzon, F Bahmer.   

Abstract

Different pigmentary characteristics as well as different parameters of sun exposure have previously been identified as risk factors for developing cutaneous melanoma. The aim of the present study was to identify significant risk factors, determine the related magnitude of their estimated relative risks, and define criteria for the detection of persons at risk. Five hundred thirteen melanoma patients and 498 controls matched for age and sex underwent a whole-body examination for the number and type of melanocytic lesions and were interviewed on ultraviolet exposure and other potential risk factors. The total number of common melanocytic nevi on all body sites represented the most important risk factor in multiple logistic regression analysis with a relative risk of 7.6 for subjects with more than 100 versus no more than 10 melanocytic nevi. Other significant independent risk factors were the number of atypical melanocytic nevi (relative risk, 6.1 for at least 5 melanocytic nevi versus none), the number of actinic lentigines (relative risk, 3.5 for many versus none), hair color, skin type, and reported melanocytic nevus growth. No single parameter of sun exposure was significantly related to melanoma risk in the multivariate analysis. Groups with an estimated relative risk between 1 and 121.0 were distinguished by considering common and atypical melanocytic nevi as well as actinic lentigines as the decisive criteria. In conclusion, even without any information on the case history, whole-body examination and diagnosis of pigmented lesions was found to be an effective strategy for identifying persons at risk of developing melanoma. Furthermore, clinical recognition of at least 5 atypical melanocytic nevi without histologic examination is a key for identifying subjects at high risk.

Entities:  

Mesh:

Year:  1994        PMID: 8176250     DOI: 10.1111/1523-1747.ep12374280

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

Authors:  J S Palmer; D L Duffy; N F Box; J F Aitken; L E O'Gorman; A C Green; N K Hayward; N G Martin; R A Sturm
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Pigmentary traits, nevi and skin phototypes in a youth population of Central Italy.

Authors:  E Ballone; M Passamonti; G Lappa; G Di Blasio; P Fazii
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

3.  Histopathological characteristics of small diameter melanocytic naevi.

Authors:  M Braun-Falco; R Hein; J Ring; N S McNutt
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

4.  Cigarette smoking and malignant melanoma: a case-control study.

Authors:  Maria C Kessides; Lee Wheless; Judith Hoffman-Bolton; Sandra Clipp; Rhoda M Alani; Anthony J Alberg
Journal:  J Am Acad Dermatol       Date:  2010-03-23       Impact factor: 11.527

Review 5.  Sun exposure and risk of melanoma.

Authors:  S A Oliveria; M Saraiya; A C Geller; M K Heneghan; C Jorgensen
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

6.  Risk Factors of Subsequent Primary Melanomas in Austria.

Authors:  Christoph Müller; Judith Wendt; Sabine Rauscher; Raute Sunder-Plassmann; Erika Richtig; Ingrid Fae; Gottfried Fischer; Ichiro Okamoto
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

Review 7.  Predicting melanoma risk: theory, practice and future challenges.

Authors:  David Whiteman
Journal:  Melanoma Manag       Date:  2014-12-04

8.  Does an increased number of moles correlate to a higher risk of melanoma?

Authors:  Mehul Bhatt; Adam Nabatian; David Kriegel; Hooman Khorasani
Journal:  Melanoma Manag       Date:  2016-05-19

9.  Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.

Authors:  J S Song; W B London; E B Hawryluk; D Guo; M Sridharan; D E Fisher; L E Lehmann; C N Duncan; J T Huang
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

10.  A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liability.

Authors:  Sri N Shekar; David L Duffy; Philippa Youl; Amanda J Baxter; Marina Kvaskoff; David C Whiteman; Adèle C Green; Maria C Hughes; Nicholas K Hayward; Marylon Coates; Nicholas G Martin
Journal:  J Invest Dermatol       Date:  2009-04-09       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.